Comparison of chemotaxis and superoxide generation in indium-111-oxine- and technetium-99m-HMPAO-labelled granulocytes

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 56, Issue 4, 1996, Pages 305-309

  Stoeckli, T C ^a   Zimmerli, W ^a   Maecke, H R ^a   Fridrich, R ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

granulocyte defect; leucocyte scintigram; phagocyte function

Indexed keywords

8 QUINOLINOL INDIUM IN 111; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; SUPEROXIDE;

ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; GRANULOCYTE; HUMAN; HUMAN CELL; ISOTOPE LABELING; LEUKOCYTE ACTIVATION; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029882918     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519609090581     Document Type: Article

References (15)

1. McAfee JG, Thakur ML. Survey of radioactive agents for in vitro labelling of phagocytic leucocytes. 1. Soluble agents. J Nucl Med 1976; 17: 480-7.
2. Peters AM, Danpure HJ, Osman S, Hawker RJ, Henderson BL, Hodgson HJ, et al. Clinical experience with Tc-99m-Hexamethylpropyleneamineoxime for labelling leucocytes and imaging inflammation. Lancet 1986; 2: 946-9.
3. Costa DC, Lui D, Ell PJ. White cells radiolabelled with In-111 and Tc-99m - a study of relative sensitivity and in vivo viability. Nucl Med Comm 1988; 9: 725-31.
4. Becker W, Schonmann E, Fischbach W, Boerner W, Gruner KR. Comparison of Tc-99m-HMPAO-and In-111-oxine-labeled granulocytes in man; first clinical results. Nucl Med Comm 1988; 9: 435-47.
5. Aktolun C, Ussov WY, Arka A, Glass D, Gunasekera RD, Peters AM. Technitium-99m and indium-111 double labelling of granulocytes for kinetic and clinical studies. Eur J Nucl Med 1995; 22: 330-4.
6. Arndt JW, van der Sluys Veer A, Blok D, Griffioen G, Verspaget HW, Lamers CBHW, et al. Prospective comparative study of technitium-99m-WBCs and indium-111-granulocytes for the examination of patients with inflammatory bowel disease. J Nucl Med 1993; 34: 1052-7.
7. Zakireh B, Thakur ML, Malech HL, Cohen MS, Gottschalk A, Root RK. Indium-111-labeled human polymorphonuclear leucocytes: viability, random migration, chemotaxis, bactericidal capacity and ultrastructure. J Nucl Med 1979; 20: 741-7.
8. 99mTc]d, 1-HM-PAO. J Nucl Med 1989; 30: 2022-28.
9. Zimmerli W, Seligmann B, Gallin JI. Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression. J Clin Invest 1986; 77: 925-33.
10. Zimmerli W, Reber A, Dahinden CA. The role of formylpeptide receptors, C5a-receptors and cytosolic-free calcium in neutrophil priming. J Infect Dis 1990; 61: 242-9.
11. Davies JM, Dineen P, Gallin J. Neutrophil degranulation and abnormal chemotaxis after thermal injury. J Immunol 1980; 124: 1467-71.
12. Donabedian H, Gallin JI. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe. J Immunol 1981; 127: 839-44.
13. Falk W, Goodwin RH Jr, Leonard EJ. A 48-well microchemotaxis assembly for rapid and accurate measurement of leukocyte migration. Immunol Meth 1980; 33: 239-7.
14. Jacob HS, Craddock PR, Hammerschmidt DE, Moldow CF. Complement-induced granulocyte aggregation. An unsuspected mechanism of disease. N Engl J Med 1980; 302: 789-94.
15. 111Inlabelled granulocytes. Relationship to labelling techniques. Scand J Haematol 1983; 30: 151-60.